Provia Laboratories™ Brings on New Stem Cell and Biobank Business Development Executive

Provia Laboratories, a leader in stem cell processing and biobanking, appoints Timothy Beals as its new Senior Director, Business Development. Provia seeks to leverage its cGMP laboratory capabilities and biobank facility into new research opportunities, expanded stem cell processing and commercial biobanking services, as well as further international expansion.

Littleton, MA (PRWEB) September 14, 2015

Provia Laboratories announced today that Timothy Beals joined Provia as the Senior Director, Business Development. Provia, who offers Store-A-Tooth™, a service to preserve the stem cells from healthy extracted teeth, recently completed a multi-million dollar investment in launching a new cGMP stem cell processing laboratory and storage facility in Littleton, MA. Combined with the reputation Store-A-Tooth developed as the leader in dental stem cell banking, Provia is poised to leverage their expertise and new cGMP facility to pursue biomedical research, cell processing beyond dental stem cells, commercial bio-banking services, and international expansion.

Beals' career spans over a period of 30 years as a regional, national and international cryopreservation specialist, and a seasoned executive focused on developing, launching and managing stem cell companies and bio-banks worldwide. He has been involved in cord blood, dental, synovial, adipose and amniotic fluid stem cell processing and banking for both clinical and research applications. With a strong understanding of the emerging and maturing needs of the clinical and research stem cell industry, Beals will lead Provia Laboratories efforts in developing additional opportunities and strategic growth.

"We are very fortunate to have Tim join our management team," said Howard Greenman, CEO of Provia Laboratories. "I've known Tim for over a decade, his experience, reputation, network, commitment and insight are exactly what Provia needs to grow and advance our role in this rapidly growing field."

"I recall over 10 years ago when the Provia team contacted me to discuss needs relating to cryopreservation of stem cells from teeth," Beals added. "At that time it was not commonly heard of, but the Provia team became early pioneers, and developed the opportunity into a rapidly growing business for Store-A-Tooth. It has been exciting to witness their growth, success and recognition in this field. This is an exciting time and opportunity for all of us here at Provia Laboratories."

The proper collection, transport, processing, testing and preservation of stem cells is a crucial and significant part of the regenerative medicine value chain. Companies have provided stem cell banking services from bone marrow, and umbilical cord blood for over two decades. More recent discoveries in the past 10 years identified additional sources of valuable stem cells derived from dental pulp, adipose and other sources. Tissues that have commonly been discarded as biological waste contain valuable tissue forming stem cells called mesenchymal stem cells, and have shown to generate growth and repair of bone, cartilage, tendon, nerve and heart tissue. Thousands of patients have been treated with stem cells and well over a million families have privately preserved stem cells for their families' own future use.

About Provia Laboratories, LLC
Provia Laboratories, LLC (http://www.provialabs.com) is a healthcare company headquartered in Littleton, MA which specializes in high-quality biobanking. Provia offers a variety of products and services for use in complex biobanking environments to improve sample logistics, security, and quality such as the Proviasette (http://www.proviasettes.com). The company advises industrial, academic, and governmental clients on matters related to the preservation of biological specimens for research and clinical use. Provia's core business, Store-A-Tooth (http://www.store-a-tooth.com) is a private stem cell bank with nearly 1000 collection sites serving clients from around the world.

For the original version on PRWeb visit: http://www.prweb.com/releases/2015/09/prweb12956947.htm